apl. Prof. Dr. Oliver Ott

Medizinische Fakultät

Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? (2020) Roedel F, Arenas M, Ott O, Fournier C, Georgakilas AG, Tapio S, Trott KR, Gaipl U Journal article, Review article Low-dose radiotherapy: Mayday, mayday. We've been hit! (2019) Ott O, Micke O, Muecke R, Niewald M, Roedel F, Schaefer U, Seegenschmiedt MH, et al. Journal article, Editorial Multimodality Treatment for Bladder Conservation (2019) Ott O Authored book Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2) (2019) Merten R, Ott O, Haderlein M, Bertz S, Hartmann A, Wullich B, Keck B, et al. Journal article Chemoradiotherapy with and without deep regional hyperthermia for squamous cell carcinoma of the anus (2018) Ott O, Schmidt M, Semrau S, Strnad V, Matzel KE, Schneider IHF, Raptis D, et al. Journal article Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott O, Kauer-Dorner D, et al. Journal article Influence of patient mispositioning on SAR distribution and simulated temperature in regional deep hyperthermia (2017) Aklan B, Gierse P, Hartmann J, Ott O, Fietkau R, Bert C Journal article Accelerated partial breast irradiation with external beam radiotherapy : First results of the German phase 2 trial (2017) Ott O, Strnad V, Stillkrieg W, Uter W, Beckmann M, Fietkau R Journal article Regional deep hyperthermia: impact of observer variability in CT-based manual tissue segmentation on simulated temperature distribution (2017) Aklan B, Hartmann J, Zink D, Siavooshhaghighi H, Merten R, Putz F, Ott O, et al. Journal article Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial (2017) Polgar C, Ott O, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, et al. Journal article